Portfolio / Aggressive
Aggressive Portfolio
High conviction, concentrated. Deep-value and turnaround picks across the cap spectrum. Higher targets with volatility-aware risk levels.
Create a tracked version of this basket so you can run rebalance checks as the universe evolves.
Cap tier filter
Intersected with tier rules — e.g. Defensive never shows Small/Micro
Portfolio brief
Stocks
9
Weighted U-Score
78.0
Avg Piotroski
7.7/9
Avg Target Upside
+66.3%
Weighted PE
14.7
Weighted ROE
26.9%
Dividend Yield
2.38%
Top-3 Concentration
41.6%
· Holding period: 1–3 years
· Cap mix: ~30% Large / 40% Mid / 30% Small
· Sector cap: 35% — top-3 concentration currently 41.6%
· Position sizing: weighted by tier strategy (defensive inverts leverage; aggressive top-heavy)
· Review cadence: quarterly rebalance recommended; replace names that fall below score threshold
Sector allocation
cap: 35% per sectorPharmaLUPIN, GLENMARK
2 stk24.5%
MetalsNATIONALUM, NMDC
2 stk24.0%
IndustrialsSUZLON, WAAREEENER
2 stk22.4%
TelecomINDUSTOWER
1 stk11.2%
FMCGGODFRYPHLP
1 stk11.2%
Financial ServicesINDIANB
1 stk6.4%
Positions
Entry at current market price. Targets use fair value where available; risk stops require ATR and recent support.
Ticker
Company
Signal
Alloc %
Entry ₹
Target ₹
Risk stop ₹
Upside
Rationale
NATIONALUMMid · U 93
National Aluminium Company Limited
Metals
▲ COMP
3–7yr
Allocation
12.8%
Entry
₹301.75
Target
₹1,296.14
Risk stop
₹280.25
Upside
+329.5%
Risk
-7.1%
MoS 76% — deep value · Piotroski 8/9 — elite balance sheet
NATIONALUM
Mid · Score 93
National Aluminium Company Limited
Metals
▲ COMP
3–7yr
12.8%
₹301.75
₹1,296.14
₹280.25
+329.5%
-7.1%
MoS 76% — deep value · Piotroski 8/9 — elite balance sheet
LUPINMid · U 83
Lupin Limited
Pharma
★ STRONG
12–24mo
Allocation
16.0%
Entry
₹1,928.9
Target
₹2,218.24
Risk stop
₹1,847.64
Upside
+15.0%
Risk
-4.2%
MoS 65% — deep value · Piotroski 8/9 — elite balance sheet
LUPIN
Mid · Score 83
Lupin Limited
Pharma
★ STRONG
12–24mo
16.0%
₹1,928.9
₹2,218.24
₹1,847.64
+15.0%
-4.2%
MoS 65% — deep value · Piotroski 8/9 — elite balance sheet
INDUSTOWERMid · U 74
Indus Towers Limited
Telecom
◆ BUY
6–18mo
Allocation
11.2%
Entry
₹380
Target
₹418
Risk stop
₹353.14
Upside
+10.0%
Risk
-7.1%
MoS 69% — deep value · Piotroski 8/9 — elite balance sheet
INDUSTOWER
Mid · Score 74
Indus Towers Limited
Telecom
◆ BUY
6–18mo
11.2%
₹380
₹418
₹353.14
+10.0%
-7.1%
MoS 69% — deep value · Piotroski 8/9 — elite balance sheet
GODFRYPHLPMid · U 77
Godfrey Phillips India Limited
FMCG
◆ BUY
6–18mo
Allocation
11.2%
Entry
₹1,669
Target
₹1,835.9
Risk stop
₹1,559.87
Upside
+10.0%
Risk
-6.5%
MoS 56% — deep value · Piotroski 8/9 — elite balance sheet
GODFRYPHLP
Mid · Score 77
Godfrey Phillips India Limited
FMCG
◆ BUY
6–18mo
11.2%
₹1,669
₹1,835.9
₹1,559.87
+10.0%
-6.5%
MoS 56% — deep value · Piotroski 8/9 — elite balance sheet
SUZLONMid · U 75
Suzlon Energy Limited
Industrials
▲ COMP
3–7yr
Allocation
12.8%
Entry
₹37.4
Target
₹90.44
Risk stop
₹34.78
Upside
+141.8%
Risk
-7.0%
MoS 57% — deep value · Piotroski 8/9 — elite balance sheet
SUZLON
Mid · Score 75
Suzlon Energy Limited
Industrials
▲ COMP
3–7yr
12.8%
₹37.4
₹90.44
₹34.78
+141.8%
-7.0%
MoS 57% — deep value · Piotroski 8/9 — elite balance sheet
WAAREEENERMid · U 75
Waaree Energies Limited
Industrials
↑ TURN
12–36mo
Allocation
9.6%
Entry
₹2,354.9
Target
₹2,825.88
Risk stop
₹2,203.71
Upside
+20.0%
Risk
-6.4%
MoS 54% — deep value · Piotroski 8/9 — elite balance sheet
WAAREEENER
Mid · Score 75
Waaree Energies Limited
Industrials
↑ TURN
12–36mo
9.6%
₹2,354.9
₹2,825.88
₹2,203.71
+20.0%
-6.4%
MoS 54% — deep value · Piotroski 8/9 — elite balance sheet
NMDCMid · U 77
NMDC Limited
Metals
◆ BUY
6–18mo
Allocation
11.2%
Entry
₹66.35
Target
₹72.99
Risk stop
₹62.5
Upside
+10.0%
Risk
-5.8%
MoS 26% — deep value · Piotroski 8/9 — elite balance sheet
NMDC
Mid · Score 77
NMDC Limited
Metals
◆ BUY
6–18mo
11.2%
₹66.35
₹72.99
₹62.5
+10.0%
-5.8%
MoS 26% — deep value · Piotroski 8/9 — elite balance sheet
INDIANBMid · U 70
Indian Bank
Financial Services
◉ GRAH
18–36mo
Allocation
6.4%
Entry
₹837.15
Target
₹1,073.98
Risk stop
₹781.12
Upside
+28.3%
Risk
-6.7%
MoS 66% — deep value · FCF yield 16.4% — cash machine
INDIANB
Mid · Score 70
Indian Bank
Financial Services
◉ GRAH
18–36mo
6.4%
₹837.15
₹1,073.98
₹781.12
+28.3%
-6.7%
MoS 66% — deep value · FCF yield 16.4% — cash machine
GLENMARKMid · U 68
Glenmark Pharmaceuticals Limited
Pharma
▲ COMP
3–7yr
Allocation
8.5%
Entry
₹2,166.6
Target
₹2,866.95
Risk stop
₹2,032.69
Upside
+32.3%
Risk
-6.2%
MoS 23% — undervalued · Piotroski 8/9 — elite balance sheet
GLENMARK
Mid · Score 68
Glenmark Pharmaceuticals Limited
Pharma
▲ COMP
3–7yr
8.5%
₹2,166.6
₹2,866.95
₹2,032.69
+32.3%
-6.2%
MoS 23% — undervalued · Piotroski 8/9 — elite balance sheet